Unilever acquires 82% stake in GSK Bangladesh’s food & drinks business
Category: #business  By Pranali Mehta  Date: 2020-06-29
  • share
  • Twitter
  • Facebook
  • LinkedIn
Unilever acquires 82% stake in GSK Bangladesh’s food & drinks business

British-Dutch consumer goods company, Unilever, has reportedly announced its acquisition of more than 82 per cent stake in GlaxoSmithKline’s food and drinks division in Bangladesh. The company has reportedly acquired these shares from Setfirst via the block market and intends to further enhance its footprint in Asia’s fast-growing economies.

According to Unilever, Setfirst had earlier expressed its intention to sell its entire holding of 98.75 lakh shares to Unilever Overseas Holdings BV showing compliance with the stock market regulator. Sources state that GSK’s stock price was Tk 1,084 when the primary agreement was drafted in 2018.

Unilever has also expressed plans to buy GSK’s entire health food and drinks division in India as well as in 20 other Asian countries for about $3.74 billion, after having stood competition against Nestle and Coca-Cola.

For the record, GSK Bangladesh’s 9,875,144 shares have been traded on the block market for a total worth of Tk 2,020.75 crore at Tk 2,046.30 each. The block market is a stock exchange platform where a large number of securities are traded in a single transaction at a negotiated price.

Sources cite that the remaining 18 per cent of GSK Bangladesh’s shares have been held by general investors owning 2.12 per cent share, institutional investors owning 15.53 per cent, and foreign investors having a share of 0.37 per cent as of February 29, 2020, states the Dhaka Stock Exchange.

Of late, Unilever had also made an announcement disclosing the official merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited which is the largest fast-moving consumer goods business in India. Unilever envisioned to evolve its food and refreshment portfolio towards scaling growth segments through this merger.

For the uninitiated, GSK is a science-led global healthcare company with its Bangladesh division, GSK Bangladesh, beginning its journey in 2002. The company provides a wide range of products including innovative medicines, vaccines, and nutrition and oral healthcare products.

 

Source Credits:

https://www.thedailystar.net/business/news/unilever-buys-82pc-stake-gsks-health-food-division-bangladesh-1922009

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Brazil’s Petrobras Resumes Oil Trade with World’s Major Traders
Brazil’s Petrobras Resumes Oil Trade with World’s Major Traders
By Pranali Mehta

Petrobras, Brazil’s state-held oil firm announced that it is restarting trades with the world’s leading oil trading houses Trafigura, Vitol, and Glencore after almost 2 years of suspension amidst a bribery inquiry in between the oil tradi...

GE Renewable receives contract to deliver onshore wind turbines
GE Renewable receives contract to deliver onshore wind turbines
By Pranali Mehta

GE Renewable Energy, the GE unit of General Electric Company, has recently announced that it has signed a wind turbine contract. Financial terms of the contract have not been disclosed. Under the terms of the contract, which has been extended by Mit...

Tesla ties up with other companies for installing solar roof tiles
Tesla ties up with other companies for installing solar roof tiles
By Pranali Mehta

Tesla has reportedly started partnering with other companies for the purpose of installing and deploying solar roof tiles at a faster pace. The company had earlier rolled out the 3rd version of its Solar Roof tiles in the month of October the previou...